HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging.

Abstract
Staphylococcus aureus is a bacterial pathogen responsible for the majority of skin and soft tissue infections. Antibiotics are losing their efficacy as treatment for skin and soft tissue infections as a result of increased resistance in a variety of pathogens, including S. aureus It is thus imperative to explore alternative antimicrobial treatments to ensure future treatment options for skin and soft tissue infections. A select few lantibiotics, a group of natural defense peptides produced by bacteria, inhibit the growth of numerous clinical S. aureus isolates, including methicillin-resistant strains. In this study, the antimicrobial activities of nisin, clausin, and amyloliquecidin, separately administered, were compared to that of a mupirocin-based ointment, which is commonly used as treatment for S. aureus-induced skin infections. Full-thickness excisional wounds, generated on the dorsal surfaces of mice, were infected with a bioluminescent strain of S. aureus (strain Xen 36). The infections were monitored in real time using in vivo bioluminescent imaging. Lantibiotic treatments significantly reduced the bioluminescence of S. aureus Xen 36 to a level similar to that recorded with mupirocin treatment. Wound closure, however, was more pronounced during lantibiotic treatment. Lantibiotics thus have the potential to be used as an alternative treatment option for S. aureus-induced skin infections.
AuthorsAnton Du Preez van Staden, Tiaan Heunis, Carine Smith, Shelly Deane, Leon M T Dicks
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 60 Issue 7 Pg. 3948-55 (07 2016) ISSN: 1098-6596 [Electronic] United States
PMID27067340 (Publication Type: Journal Article)
CopyrightCopyright © 2016, American Society for Microbiology. All Rights Reserved.
Chemical References
  • Anti-Infective Agents
  • Bacteriocins
  • Nisin
  • nisin A
Topics
  • Animals
  • Anti-Infective Agents (therapeutic use)
  • Bacteriocins (therapeutic use)
  • Female
  • Luminescent Measurements (methods)
  • Mice
  • Mice, Nude
  • Nisin (therapeutic use)
  • Soft Tissue Infections (drug therapy, microbiology)
  • Staphylococcal Skin Infections (drug therapy, microbiology)
  • Staphylococcus aureus (drug effects, pathogenicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: